Live Dana-Farber Cancer Institute News with Latest Updates

Live Dana-Farber Cancer Institute news and developments with the latest updates. Check out current Dana-Farber Cancer Institute news stories and find out what happened, what is going on with Dana-Farber Cancer Institute. Recent news updates about Dana-Farber Cancer Institute
Two Dana-Farber faculty members elected as Fellows of American Association for Advancement of Science
BICRA gene provides answers to patients, doctors and scientists
Dana-Farber Cancer Institute and Quest Diagnostics collaborate to identify prevalence of COVID-19
Dana-Farber Cancer Institute partners with Prostate Cancer Foundation to advance prostate cancer treatment for
Dana-Farber/Brigham and Women’s Cancer Center and Stamford Hospital announce expanded collaboration
Dana-Farber Cancer Institute at top of 2020 Top 100 Women-Led Businesses in Massachusetts
Medicaid expansion linked to lower mortality rates for three major types of cancer
Experts release new management strategies for malignant colorectal polyps
Targeted inhibitor of mutated KRAS gene shows promise in early trial for lung, bowel, and other solid tumors
Dana-Farber faculty member Myles Brown, MD elected to National Academy of Medicine
Researchers identify mechanism behind bone marrow failure in Fanconi anaemia
New 3-D model of a DNA-regulating complex in human cells provides cancer clues
Dana-Farber/Harvard Cancer Center wins prestigious federal grant to accelerate ovarian cancer research
Dana-Farber leader, Laurie H. Glimcher, is recipient of public service award
Study offers global review of impact of COVID-19 on cancer treatment and research
Dana-Farber announces Center for Salivary and Rare Head and Neck Cancers
Genetic test identifies patients with invasive lobular breast cancer at high risk of disease recurrence
Boston Medical Center, Dana-Farber Cancer Institute, Massachusetts General Hospital Formalize Cancer Clinical Trial
Local women leaders hear about revolutionary developments in women’s cancer research at Dana-Farber Cancer
Expanding access to world’s top medical minds
Lesley Solomon of Dana-Farber Cancer Institute receives an Extraordinary Women Advancing Healthcare award
Keeping cancer clinical research on track during a pandemic
Jeannie and Jonathan Lavine Establish Lavine Family Fund for Preventative Cancer Therapies
Trial finds benefit of immunotherapy-chemotherapy combination in early-stage triple-negative breast cancer
Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer
Dana-Farber Cancer Institute earns “LGBTQ Health Care Equality Leader” Designation in Human Rights Campaign
Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer
Study provides molecular look at how healthy muscle adapts to exercise
Study sheds light on some tumors’ ability to evade a promising immunotherapy strategy
Dana-Farber opens clinical trial to evaluate simple blood test for many types of cancer
Dozier Gardner Family Announces Gift to Establish Fund at Dana-Farber Cancer Institute
Dana-Farber researcher awarded Victoria Mock New Investigator Award 9 September
Dana-Farber Cancer Institute to establish Benderson Family Program for triple-negative breast cancer
Dana-Farber collaborates with Mass. Eye and Ear to rebuild damaged corneas using patients’ own stem cells for first
Dana-Farber launches new Center for prevention and treatment of BRCA-related cancers
Using models, 3D printing to study common heart defect
Dana-Farber study advances understanding of rare sarcoma
Dana-Farber/Brigham and Women’s Cancer Center is ranked best in New England
Dana-Farber to offer first CAR T-cell therapy for mantle cell lymphoma following FDA approval
Prostate cancer metastasis linked to revival of dormant molecular program
Three Dana-Farber physician scientists receive Doris Duke Charitable Foundation 2020 Clinical Scientist Development
Statement on U.S. Court of Appeals ruling regarding joint inventorship of six immnunotherapy patents
St. Jude researchers create an analytic tool that opens a new frontier of cancer discovery
How cancer drugs find their targets
Dana-Farber faculty recognized with AACR 2020 Team Science Awards
Dana-Farber researcher receives highest honor from Society for Immunotherapy of Cancer
Online program significantly improves insomnia in adolescent and young adult cancer survivors, study finds
Vitamin D May Help Prevent a Common Side Effect of Anti-Cancer Immunotherapy